Skip to content

Product brand

Unclaimed

DrSmile is a German dental brand offering clear-aligner treatments through a network of partner dentists and orthodontists.

Last updated August 31, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

DrSmile is a German dental brand operated by Urban Technology GmbH, a Berlin-based startup. The company was founded in 2016 by Jens Urbaniak and Christopher von Wedemeyer. Urbaniak had previously worked at Rocket Internet and co-founded the service startup Go Butler, while von Wedemeyer had worked as an investment-banking analyst. DrSmile developed a consumer-oriented model for aesthetic orthodontic treatment, using clear, removable aligners intended primarily for minor and medium tooth misalignments. The brand's operating model combines digital customer acquisition with treatment delivered through a network of dentists and orthodontists. DrSmile has maintained locations in several major German cities, including Berlin, Düsseldorf, Frankfurt, Hamburg, Cologne, Munich, Nuremberg, Stuttgart and Hannover. Its aligners are produced with 3D-printing technology, while clinical treatment is presented as being conducted in cooperation with dental professionals. This positioned DrSmile within the expansion of direct-to-consumer and digitally enabled orthodontic services in Europe. The company attracted major strategic investment in July 2020, when Swiss dental-implant manufacturer Straumann announced the purchase of a majority stake for CHF 110 million and obtained an option to acquire the remaining shares. In May 2022, DrSmile acquired PlusDental, another European dental-alignment startup, in a transaction reported at €131 million. The acquisition expanded the group's position in the digital orthodontics market, although the reported transaction value is not independently detailed in the available reference material. DrSmile has also faced regulatory and professional criticism. Some dental professionals have questioned aligner models that involve limited direct examination or the taking of dental impressions at home. Critics have argued that orthodontic treatment requires sufficiently thorough clinical assessment and continuing professional oversight. DrSmile has stated that it works with dentists and orthodontists and has distinguished its approach from models that exclude professional consultation. A German court ruled in 2019 that certain practices did not meet applicable dental standards. In March 2024, Poland's Office of Competition and Consumer Protection imposed a fine of PLN 2,782,817 over actions it considered harmful to the collective interests of consumers. The same authority also imposed a further PLN 674,622 penalty concerning a prohibited contractual clause; the latter decision was reported as not final. In August 2024, Straumann announced an agreement to sell its DrSmile aligner business to Impress Group, a Barcelona-based clear-aligner provider. The available material does not establish whether the transaction was completed, the precise continuing ownership structure, or the brand's current corporate status. Accordingly, DrSmile's present ownership and operating status should be verified against current corporate and regulatory sources.

History

DrSmile emerged in Berlin in 2016, founded by Jens Urbaniak and Christopher von Wedemeyer. The founders brought backgrounds associated with technology startups and investment banking, and built the brand around a digitally coordinated approach to aesthetic orthodontics. Its central offering was a series of transparent, removable aligners intended to correct minor and medium tooth misalignments. The company used digital processes and 3D-printing technology in the production of its aligners and organized treatment through a network of partner dentists and orthodontists. The brand expanded its presence in Germany through locations in Berlin, Düsseldorf, Frankfurt, Hamburg, Cologne, Munich, Nuremberg, Stuttgart and Hannover. Its proposition addressed consumers seeking a less visible alternative to conventional fixed braces, while its commercial model reflected the broader growth of digitally marketed healthcare and direct-to-consumer orthodontic services. A major corporate turning point came in July 2020, when Straumann, a Swiss dental-implant manufacturer, announced that it had acquired a majority stake in DrSmile for CHF 110 million and had obtained an option for the remaining shares. This brought DrSmile into the orbit of a major international dental company and gave the aligner business a strategic owner with established industry capabilities. In May 2022, DrSmile acquired PlusDental for a reported €131 million, consolidating two European digital dental businesses and strengthening its position in the clear-aligner sector. The brand's model generated debate within the dental profession. Critics of remote or highly standardized aligner services raised concerns about whether patients received adequate examination, diagnosis and clinical monitoring. Particular criticism focused on approaches in which patients made impressions of their teeth at home without direct supervision from a dentist. DrSmile maintained that it worked with dentists and orthodontists and differentiated itself from services that omitted professional consultation. Nevertheless, a German court ruled in 2019 that certain dental standards had not been met. The controversy was accompanied by negative customer reviews alleging communication problems and aggressive sales practices; these allegations should be treated as reported criticism rather than established findings unless supported by specific adjudicated records. Regulatory scrutiny continued in Poland. In March 2024, Poland's Office of Competition and Consumer Protection imposed a PLN 2,782,817 fine concerning conduct that allegedly violated the collective interests of consumers. A separate PLN 674,622 penalty was associated with a prohibited contractual clause, although that decision was reported as not final. The available material also refers to an investigation by a public office into arrangements involving DZK Deutsche Zahnklinik GmbH, but does not provide enough detail to characterize the investigation's outcome. In August 2024, Straumann announced an agreement to sell its DrSmile aligner business to Impress Group, a Barcelona-based clear-aligner provider. The available reference does not confirm completion of the sale or clarify whether all DrSmile operations, contracts and markets transferred. Current ownership, management and operating status therefore remain subjects for verification.

  • 2024

    Polish consumer penalties

    [1]

    Poland's competition and consumer authority announces fines relating to consumer-interest violations and a prohibited contractual clause.

  • 2024

    Proposed sale to Impress Group

    [1]

    Straumann announces an agreement to sell its DrSmile aligner business to Impress Group; completion is not established in the available material.

  • 2022

    PlusDental acquisition

    [1]

    DrSmile acquires PlusDental in a transaction reported at €131 million.

  • 2020

    Straumann acquires a majority stake

    [1]

    Straumann announces a CHF 110 million majority investment and an option to purchase the remaining shares.

  • 2019

    German court addresses dental standards

    [1]

    A German court rules that certain elements of the treatment approach did not meet applicable dental standards.

  • 2016

    DrSmile is founded in Berlin

    [1]

    Jens Urbaniak and Christopher von Wedemeyer establish the dental brand and begin developing a digitally coordinated clear-aligner business.

Products and positioning

A consumer-facing European dental brand combining digital acquisition and treatment coordination with a network of dentists and orthodontists, focused on aesthetic correction using invisible clear aligners.

  • Orthodontic treatment

    DrSmile clear aligners

    A series of transparent, removable dental aligners designed for aesthetic orthodontic treatment. The brand focuses on minor and medium misalignments of the teeth. Treatment is coordinated through DrSmile's partner network of dentists and orthodontists, and the aligners are produced using 3D-printing technology.

Controversies

  • 2024

    Polish consumer-protection penalties

    Poland's Office of Competition and Consumer Protection imposed a PLN 2,782,817 fine over conduct it considered contrary to collective consumer interests. It also imposed a PLN 674,622 penalty concerning a prohibited contractual clause; the latter decision was reported as not final.

  • 2019

    Court finding concerning dental-treatment standards

    A German court ruled that certain aspects of DrSmile's treatment approach did not satisfy applicable dental standards, in the context of wider concerns about remote examination and professional supervision.

  • Professional criticism of remote aligner treatment

    Dental professionals have criticized aligner models that may involve home impressions or limited direct examination, raising questions about diagnosis, treatment suitability and clinical monitoring. The available material describes this as an area of controversy rather than a single resolved proceeding.

Read more

Brand decisions

  • 2024

    Agree to sale of the aligner business to Impress GroupM&A

    Background

    Straumann announced a restructuring of its aligner activities and identified Impress Group as the buyer for the DrSmile aligner business.

    Action taken

    Straumann signed an agreement to sell the DrSmile aligner business to Barcelona-based Impress Group.

    Aftermath

    The available reference does not confirm closing of the transaction or the resulting ownership and management structure.

  • 2022

    Acquire PlusDentalM&A

    Background

    The acquisition consolidated two European digital dental and clear-aligner businesses.

    Action taken

    DrSmile acquired PlusDental in a transaction reported at €131 million.

    Aftermath

    The deal expanded DrSmile's scale and market position, although detailed integration outcomes are not provided in the available material.

    Reported transaction value. €131 million (May 2022)

  • 2020

    Accept majority investment from StraumannM&A

    Background

    DrSmile sought to expand within the European digital orthodontics market while Straumann was building a position in clear aligners and related dental technologies.

    Action taken

    Straumann acquired a majority stake for CHF 110 million and secured an option on the remaining shares.

    Aftermath

    DrSmile became associated with a major international dental manufacturer. The transaction value and timing are reported in the cited reference.

    Reported investment value. CHF 110 million (July 2020)

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/drsmile · Editorial policy · How profiles are compiled